Nutrien misses estimates, lowers outlook
16:01 PM | November 5, 2019 | Rebecca Coons
Full-year outlook for adjusted earnings is now $2.30–2.55/share, down from previous forecast of $2.70–3.00/share.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.